MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Data presented as a Late Breaking Clinical Trial at Heart Rhythm 2011, the Heart Rhythm Society’s 32nd Annual Scientific Sessions, shows the clinical benefit of cardiac resynchronization therapy (CRT) versus conventional right-ventricle (RV) pacing in improving heart failure (HF) in patients undergoing atrioventricular (AV) junction ablation for permanent atrial fibrillation (AF). In the clinical trial, patients receiving CRT had a 26 percent reduction in the primary composite endpoint of death from HF, hospitalization from HF, or worsening HF when compared to patients undergoing RV pacing (11 percent).
